Literature DB >> 11884615

Opposing roles of the extracellular signal-regulated kinase and p38 mitogen-activated protein kinase cascades in Ras-mediated downregulation of tropomyosin.

Janiel M Shields1, Heena Mehta, Kevin Pruitt, Channing J Der.   

Abstract

We showed previously that activated Ras, but not Raf, causes transformation of RIE-1 epithelial cells, demonstrating the importance of Raf-independent pathways in mediating Ras transformation. To assess the mechanism by which Raf-independent effector signaling pathways contribute to Ras-mediated transformation, we recently utilized representational difference analysis to identify genes expressed in a deregulated fashion by activated Ras but not Raf. One gene identified in these analyses encodes for alpha-tropomyosin. Therefore, we evaluated the mechanism by which Ras causes the downregulation of tropomyosin expression. By using RIE-1 cells that harbor inducible expression of activated H-Ras(12V), we determined that the downregulation of tropomyosin expression correlated with the onset of morphological transformation. We found that the reversal of Ras transformation caused by inhibition of extracellular signal-regulated kinase activation corresponded to a restoration of tropomyosin expression. Inhibition of p38 activity in Raf-expressing RIE-1 cells caused both morphological transformation and loss of tropomyosin expression. Thus, a reduction in tropomyosin expression correlated strictly with morphological transformation of RIE-1 cells. However, forced overexpression of tropomyosin in Ras-transformed cells did not reverse morphological or growth transformation, a finding consistent with the possibility that multiple changes in gene expression contribute to Ras transformation. We also determined that tropomyosin expression was low in two human tumor cell lines, DLD-1 and HT1080, that harbor endogenous mutated alleles of ras, but high in transformation-impaired, derivative cell lines in which the mutant ras allele has been genetically deleted. Finally, treatment with azadeoxycytidine restored tropomyosin expression in Ras-transformed RIE-1, HT1080, and DLD-1 cells, suggesting a role for DNA methylation in downregulating tropomyosin expression.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11884615      PMCID: PMC133695          DOI: 10.1128/MCB.22.7.2304-2317.2002

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  71 in total

Review 1.  Ras effectors.

Authors:  C J Marshall
Journal:  Curr Opin Cell Biol       Date:  1996-04       Impact factor: 8.382

Review 2.  Functional properties of non-muscle tropomyosin isoforms.

Authors:  M F Pittenger; J A Kazzaz; D M Helfman
Journal:  Curr Opin Cell Biol       Date:  1994-02       Impact factor: 8.382

3.  Regulation of the DNA methyltransferase by the Ras-AP-1 signaling pathway.

Authors:  J Rouleau; A R MacLeod; M Szyf
Journal:  J Biol Chem       Date:  1995-01-27       Impact factor: 5.157

4.  Expression, cytoskeletal utilization and dimer formation of tropomyosin derived from retroviral-mediated cDNA transfer. Metabolism of tropomyosin from transduced cDNA.

Authors:  G L Prasad; R A Fuldner; R Braverman; E McDuffie; H L Cooper
Journal:  Eur J Biochem       Date:  1994-08-15

5.  Phosphatidylinositol-3-OH kinase as a direct target of Ras.

Authors:  P Rodriguez-Viciana; P H Warne; R Dhand; B Vanhaesebroeck; I Gout; M J Fry; M D Waterfield; J Downward
Journal:  Nature       Date:  1994-08-18       Impact factor: 49.962

6.  Restoration of microfilament bundle organization in v-raf-transformed NRK cells after transduction with tropomyosin 2 cDNA.

Authors:  K Takenaga; A Masuda
Journal:  Cancer Lett       Date:  1994-11-25       Impact factor: 8.679

7.  Identification of genes differentially expressed in association with metastatic potential of K-1735 murine melanoma by messenger RNA differential display.

Authors:  Y Hashimoto; N Shindo-Okada; M Tani; K Takeuchi; H Toma; J Yokota
Journal:  Cancer Res       Date:  1996-11-15       Impact factor: 12.701

8.  New 5' regions of the murine and human genes for DNA (cytosine-5)-methyltransferase.

Authors:  J A Yoder; R W Yen; P M Vertino; T H Bestor; S B Baylin
Journal:  J Biol Chem       Date:  1996-12-06       Impact factor: 5.157

9.  Rearrangement of the MLL gene in acute lymphoblastic and acute myeloid leukemias with 11q23 chromosomal translocations.

Authors:  M J Thirman; H J Gill; R C Burnett; D Mbangkollo; N R McCabe; H Kobayashi; S Ziemin-van der Poel; Y Kaneko; R Morgan; A A Sandberg
Journal:  N Engl J Med       Date:  1993-09-23       Impact factor: 91.245

10.  Dbl and Vav mediate transformation via mitogen-activated protein kinase pathways that are distinct from those activated by oncogenic Ras.

Authors:  R Khosravi-Far; M Chrzanowska-Wodnicka; P A Solski; A Eva; K Burridge; C J Der
Journal:  Mol Cell Biol       Date:  1994-10       Impact factor: 4.272

View more
  13 in total

Review 1.  Interior decoration: tropomyosin in actin dynamics and cell migration.

Authors:  Justin G Lees; Cuc T T Bach; Geraldine M O'Neill
Journal:  Cell Adh Migr       Date:  2011-03-01       Impact factor: 3.405

2.  p38α Signaling Induces Anoikis and Lumen Formation During Mammary Morphogenesis.

Authors:  Huei-Chi Wen; Alvaro Avivar-Valderas; Maria Soledad Sosa; Nomeda Girnius; Eduardo F Farias; Roger J Davis; Julio A Aguirre-Ghiso
Journal:  Sci Signal       Date:  2011-05-24       Impact factor: 8.192

Review 3.  New insights into the regulation of the actin cytoskeleton by tropomyosin.

Authors:  C-L Albert Wang; Lynne M Coluccio
Journal:  Int Rev Cell Mol Biol       Date:  2010       Impact factor: 6.813

4.  Overexpression of kinase suppressor of Ras upregulates the high-molecular-weight tropomyosin isoforms in ras-transformed NIH 3T3 fibroblasts.

Authors:  Richard A J Janssen; Phillia N Kim; James W Mier; Deborah K Morrison
Journal:  Mol Cell Biol       Date:  2003-03       Impact factor: 4.272

5.  Identification of squamous cell carcinoma associated proteins by proteomics and loss of beta tropomyosin expression in esophageal cancer.

Authors:  Ferdous-Rastgar Jazii; Zahra Najafi; Reza Malekzadeh; Thomas-P Conrads; Abed-Ali Ziaee; Christian Abnet; Mansour Yazdznbod; Ali-Asghar Karkhane; Ghasem-H Salekdeh
Journal:  World J Gastroenterol       Date:  2006-11-28       Impact factor: 5.742

6.  A critical role of tropomyosins in TGF-beta regulation of the actin cytoskeleton and cell motility in epithelial cells.

Authors:  Andrei V Bakin; Alfiya Safina; Cammie Rinehart; Cecilia Daroqui; Huferesh Darbary; David M Helfman
Journal:  Mol Biol Cell       Date:  2004-08-18       Impact factor: 4.138

7.  RasV12-mediated down-regulation of CCAAT/enhancer binding protein beta in immortalized fibroblasts requires loss of p19Arf and facilitates bypass of oncogene-induced senescence.

Authors:  Thomas Sebastian; Peter F Johnson
Journal:  Cancer Res       Date:  2009-03-10       Impact factor: 12.701

8.  BMP9 signaling in stem cell differentiation and osteogenesis.

Authors:  Joseph D Lamplot; Jiaqiang Qin; Guoxin Nan; Jinhua Wang; Xing Liu; Liangjun Yin; Justin Tomal; Ruidong Li; Wei Shui; Hongyu Zhang; Stephanie H Kim; Wenwen Zhang; Jiye Zhang; Yuhan Kong; Sahitya Denduluri; Mary Rose Rogers; Abdullah Pratt; Rex C Haydon; Hue H Luu; Jovito Angeles; Lewis L Shi; Tong-Chuan He
Journal:  Am J Stem Cells       Date:  2013-03-08

9.  Romidepsin inhibits Ras-dependent growth transformation of NIH 3T3 fibroblasts and RIE-1 epithelial cells independently of Ras signaling inhibition.

Authors:  Ariella B Hanker; Kevin D Healy; Jean Nichols; Channing J Der
Journal:  J Mol Signal       Date:  2009-08-16

10.  P38 and ERK1/2 MAPKs act in opposition to regulate BMP9-induced osteogenic differentiation of mesenchymal progenitor cells.

Authors:  Yingze Zhao; Tao Song; Wenjuan Wang; Jin Wang; Juanwen He; Ningning Wu; Min Tang; Baicheng He; Jinyong Luo
Journal:  PLoS One       Date:  2012-08-17       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.